![]() |
| Some bacterial pathogens play dead to dodge antibiotics. A new test watches them closely—and helps choose drugs that finish the job Image Credit: Scientific Frontline / AI generated |
Scientific Frontline: "At a Glance" Summary
- Researchers at the University of Basel and University Hospital Basel developed "antimicrobial single-cell testing," a novel method that precisely measures the lethality of antibiotics against bacteria rather than merely their ability to inhibit growth.
- The technique utilizes high-throughput microscopic imaging to film millions of individual bacteria under thousands of conditions over several days, tracking the survival and death kinetics of each cell in real-time.
- Validation involved testing 65 combination therapies on Mycobacterium tuberculosis and analyzing bacterial samples from 400 patients infected with Mycobacterium abscessus.
- Unlike traditional susceptibility tests that often fail to detect dormant bacteria capable of reviving post-treatment, this approach identifies "antibiotic tolerance," where pathogens survive exposure without reproducing.
- This technology enables personalized medicine by tailoring antibiotic regimens to a patient's specific bacterial strain and offers a more accurate predictor of therapeutic success than current clinical or animal model data.

_MoreDetail-v3_x2_1500x1000.jpg)





.jpg)

.jpg)